Day2, July 6, 12:30 p.m., Session B:
The bavarian therapeutic strategy to combat the COVID 19 pandemic
William Menzer is currently a third year PhD student with Eisbach Bio, where he handles all of the chemistry work – from computational docking and AI based binding predictions, through classical medicinal chemistry, all the way to coordination of GMP upscales and CMC duties. William started his journey toward his current role at Eisbach by completing his bachelor’s and master’s degrees in molecular biochemistry and biophysics at Illinois Tech in 2019 in Chicago, only a short distance from where he grew up. He moved to Munich after being accepted into the IMPRS-LS program as a PhD student with Andreas Ladurner in 2019 and started at Eisbach shortly thereafter.
Copyright © 2022 BioM Biotech Cluster Development GmbH
Alle Rechte vorbehalten